Ivabradine: A Potential Therapeutic for Children With Refractory SVT

Younis, NK; Abi-Saleh, B; Al Amin, F; El Sedawi, O; Tayeh, C; Bitar, F; Arabi, M

Arabi, M (corresponding author), Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon.; Arabi, M (corresponding author), Amer Univ Beirut, Med Ctr, Pediat Dept, Div Pediat Cardiol, Beirut, Lebanon.

FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021; 8 ():

Abstract

Background: In April 2015, ivabradine was approved by the Food and Drug Administration for the treatment of patients with coronary artery disease and ......

Full Text Link